Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer | Molecular Cancer
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list